Back to Results
First PageMeta Content
Amyotrophic lateral sclerosis / Motor neurone disease / Pharmaceutical industry / James Heywood / ALS Association / Rare diseases / Health / ALS Therapy Development Institute


Anelixis Therapeutics to Provide Pipeline of Clinical Candidates for ALS
Add to Reading List

Document Date: 2014-02-10 09:02:54

Open Document

File Size: 364,03 KB

Share Result on Facebook

City

CAMBRIDGE / New York / /

Company

Novartis / Anelixis Therapeutics LLC / /

Country

Switzerland / /

Event

FDA Phase / Company Expansion / /

Facility

Provide Pipeline of Clinical Candidates / Anelixis’ pipeline / About ALS Therapy Development Institute / ALS Therapy Development Institute / /

IndustryTerm

biotechnology executives / virtual biotechnology / biotechnology / larger biotechnology / pharmaceutical / publicly-traded biotechnology / /

MedicalCondition

MND / Lou Gehrig’s disease / ALS / /

Organization

ALS Therapy Development Institute / /

Person

Steve Perrin / Lou Gehrig / /

/

Position

BIO CEO / CEO / Annual BIO CEO / /

Product

Gilenya / Gilenya® / ALS / /

Technology

biotechnology / drug development / /

URL

www.als.net / www.AnelixisTherapeutics.com / /

SocialTag